- Home
- GGAL vs ACLX Comparison
GGAL vs ACLX Comparison
Compare GGAL & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GGAL
- ACLX
- Stock Information
- Founded
- GGAL 1905
- ACLX 2015
- Country
- GGAL Argentina
- ACLX United States
- Employees
- GGAL N/A
- ACLX N/A
- Industry
- GGAL Commercial Banks
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- GGAL Finance
- ACLX Health Care
- Exchange
- GGAL Nasdaq
- ACLX Nasdaq
- Market Cap
- GGAL 5.2B
- ACLX 4.4B
- IPO Year
- GGAL N/A
- ACLX 2022
- Fundamental
- Price
- GGAL $52.32
- ACLX $86.90
- Analyst Decision
- GGAL Buy
- ACLX Strong Buy
- Analyst Count
- GGAL 4
- ACLX 12
- Target Price
- GGAL $75.67
- ACLX $113.08
- AVG Volume (30 Days)
- GGAL 4.1M
- ACLX 535.1K
- Earning Date
- GGAL 01-01-0001
- ACLX 11-07-2025
- Dividend Yield
- GGAL 1.34%
- ACLX N/A
- EPS Growth
- GGAL N/A
- ACLX N/A
- EPS
- GGAL 0.60
- ACLX N/A
- Revenue
- GGAL $4,565,013,669.00
- ACLX $56,979,000.00
- Revenue This Year
- GGAL $9.54
- ACLX N/A
- Revenue Next Year
- GGAL $12.92
- ACLX $210.73
- P/E Ratio
- GGAL $9.09
- ACLX N/A
- Revenue Growth
- GGAL N/A
- ACLX N/A
- 52 Week Low
- GGAL $25.89
- ACLX $47.86
- 52 Week High
- GGAL $74.00
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- GGAL 81.00
- ACLX 57.68
- Support Level
- GGAL $31.14
- ACLX $82.64
- Resistance Level
- GGAL $53.38
- ACLX $88.58
- Average True Range (ATR)
- GGAL 2.69
- ACLX 3.36
- MACD
- GGAL 2.59
- ACLX -0.50
- Stochastic Oscillator
- GGAL 95.26
- ACLX 37.23
About GGAL Grupo Financiero Galicia S.A.
Grupo Financiero Galicia SA is a financial service holding company. It provides general banking services, proprietary brand credit card services, personal loans, insurance, and other services. The company's operating business segments are Banks, Ecosistema Naranja X, Insurance, Adjustments, and Other Businesses. It generates maximum revenue from Banks. Geographically its operate in Argentina, Uruguay, and the majority of its revenue comes from Argentina.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.